Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent

J Am Geriatr Soc. 2008 Feb;56(2):371-3. doi: 10.1111/j.1532-5415.2007.01522.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Cabergoline
  • Cardiovascular Diseases / chemically induced*
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Ergolines / adverse effects*
  • Ergolines / therapeutic use
  • Female
  • Humans
  • Male
  • Parkinson Disease / drug therapy*
  • Pergolide / adverse effects*
  • Pergolide / therapeutic use
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Ergolines
  • Pergolide
  • Cabergoline